Virtus LifeSci Biotech Clinical Trials ETF Rating $26.32 +0.15 (+0.57%) (As of 02:35 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.91Holdings in BBC have an aggregate rating of Moderate Buy based on 397 analyst ratings issued in the past year covering 49 companies (56.9% of the portfolio).BBC Aggregate Price Target$26.32High Prediction$26.32Average Prediction$26.32Low Prediction$26.32Holdings in BBC have an aggregate price target of $26.32 and a range of $26.32 to $26.32 covering 49 companies (56.9% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy28 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.36%LBPHLongboard Pharmaceuticals$59.760.0%1.4731 of 5 stars2.44$59.56 -0.3%92.29%SRRKScholar Rock$27.11-2.7%4.6007 of 5 stars3.14$34.00 25.4%71.91%WVEWave Life Sciences$14.51+1.8%4.8617 of 5 stars3.00$22.22 53.2%10Analyst ForecastAnalyst Revision1.90%SMMTSummit Therapeutics$18.66+0.2%1.8883 of 5 stars2.75$34.75 86.2%4Analyst Forecast1.61%PRAXPraxis Precision Medicines$73.43-0.3%1.778 of 5 stars2.89$146.33 99.3%91.49%ZYMEZymeworks$13.84-4.9%2.4109 of 5 stars2.83$19.00 37.3%61.47%EWTXEdgewise Therapeutics$32.21+0.8%1.7413 of 5 stars3.00$38.40 19.2%51.44%CNTACentessa Pharmaceuticals$17.83+6.5%4.0687 of 5 stars3.00$25.83 44.9%61.42%ACLXArcellx$87.93+0.8%2.9367 of 5 stars3.07$103.08 17.2%14Short Interest ↓1.35%VRDNViridian Therapeutics$20.10+1.6%2.3617 of 5 stars2.80$36.33 80.8%10Analyst Revision1.34%APLTApplied Therapeutics$9.39-0.4%4.362 of 5 stars3.17$12.50 33.1%61.30%BLTEBelite Bio$82.500.0%1.1198 of 5 stars3.00$89.00 7.9%4Analyst Revision1.28%NRIXNurix Therapeutics$22.67+0.1%2.7301 of 5 stars2.93$29.40 29.7%151.27%IRONDisc Medicine$63.06+0.8%3.1771 of 5 stars3.10$85.80 36.1%10Insider TradeAnalyst Revision1.16%RVMDRevolution Medicines$56.97-0.2%2.7998 of 5 stars3.08$61.00 7.1%121.16%BHVNBiohaven$46.05-1.7%3.9334 of 5 stars3.07$63.42 37.7%141.11%IGMSIGM Biosciences$8.73-10.6%4.7096 of 5 stars2.38$16.13 84.7%81.10%KYMRKymera Therapeutics$43.66-0.9%1.4142 of 5 stars2.81$52.13 19.4%16Analyst Forecast1.08%SLRNAcelyrin$4.34-2.0%3.3968 of 5 stars2.50$11.50 165.0%6Analyst RevisionPositive NewsGap Down1.06%ORICORIC Pharmaceuticals$8.90+1.8%4.207 of 5 stars3.00$18.29 105.5%8Analyst RevisionGap Up1.06%DNLIDenali Therapeutics$24.33-0.4%4.4921 of 5 stars2.73$38.90 59.9%111.04%RNAAvidity Biosciences$42.98-1.5%2.3728 of 5 stars3.00$63.22 47.1%9Insider TradeAnalyst Revision1.04%VERAVera Therapeutics$47.31+3.4%2.609 of 5 stars3.10$59.22 25.2%10Analyst ForecastGap Up1.03%ERASErasca$2.58-2.3%2.8149 of 5 stars2.83$6.08 135.8%6Analyst ForecastAnalyst Revision1.03%PCVXVaxcyte$88.98+3.5%3.3048 of 5 stars3.00$147.50 65.8%71.02%QUREuniQure$5.86+2.8%3.0933 of 5 stars2.67$17.00 190.1%6News CoverageNegative News1.00%NAMSNewAmsterdam Pharma$20.20+0.9%2.9471 of 5 stars3.00$33.80 67.3%7Analyst ForecastInsider TradeNews CoverageHigh Trading Volume1.00%KROSKeros Therapeutics$54.53+0.7%3.5164 of 5 stars3.00$88.89 63.0%121.00%SAVACassava Sciences$32.63+25.3%3.8449 of 5 stars3.00$111.50 241.7%2High Trading Volume0.99%CRNXCrinetics Pharmaceuticals$57.09+1.8%2.8397 of 5 stars2.91$70.18 22.9%11Analyst Revision0.99%AKROAkero Therapeutics$30.78+0.5%4.0609 of 5 stars2.88$46.83 52.2%8Analyst ForecastInsider Trade0.98%REPLReplimune Group$11.00-2.0%4.1583 of 5 stars3.17$16.80 52.7%60.98%PTGXProtagonist Therapeutics$41.11+1.1%3.0296 of 5 stars3.14$53.57 30.3%7Analyst ForecastAnalyst RevisionNews Coverage0.98%SLNOSoleno Therapeutics$55.15+0.6%4.0001 of 5 stars3.14$74.83 35.7%70.97%JANXJanux Therapeutics$46.10-5.8%3.6103 of 5 stars2.90$66.44 44.1%100.97%APGEApogee Therapeutics$43.82-2.7%2.4739 of 5 stars3.00$78.50 79.1%60.95%MLTXMoonLake Immunotherapeutics$51.73+3.8%3.2872 of 5 stars2.90$79.00 52.7%100.93%ELVNEnliven Therapeutics$25.31-0.5%2.3747 of 5 stars3.25$37.00 46.2%40.93%EXAIExscientia$4.842.2668 of 5 stars2.00$7.00 44.6%4News Coverage0.91%ABUSArbutus Biopharma$3.49+1.5%2.8223 of 5 stars3.00$5.50 57.6%4Analyst Forecast0.91%COGTCogent Biosciences$9.07-0.1%2.8854 of 5 stars2.71$14.83 63.5%7Analyst Revision0.91%PLRXPliant Therapeutics$13.03+2.4%3.5146 of 5 stars3.11$40.57 211.4%90.90%NUVLNuvalent$93.46+2.5%2.1908 of 5 stars2.85$112.60 20.5%130.88%CRGXCARGO Therapeutics$15.94+0.8%1.6833 of 5 stars3.00$30.33 90.3%70.88%ARQTArcutis Biotherapeutics$10.42+2.4%1.7656 of 5 stars2.75$15.50 48.8%40.87%PHVSPharvaris$20.69+0.9%1.4783 of 5 stars2.60$33.60 62.4%50.87%XENEXenon Pharmaceuticals$40.23+2.3%3.5315 of 5 stars3.08$57.45 42.8%12Analyst Revision0.87%XNCRXencor$23.97+1.1%3.5832 of 5 stars3.00$35.75 49.1%80.86%ANNXAnnexon$5.33+3.3%2.7858 of 5 stars3.00$15.80 196.4%6Analyst Revision This page (NYSEARCA:BBC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
